Ashleigh Furlong
POLITICO Europe
United Kingdom
Contact Ashleigh
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Ashleigh:
AI is about to remake the pharmaceutical industry
Algorithm-designed drugs are entering human trials. → Read More
So much for coordination: EU countries ignore pandemic lessons amid China’s COVID surge
Division over travel measures highlights haphazard EU response. → Read More
‘Paradigm shift’ in cancer treatment as Moderna’s vaccine shows promise
Preliminary results raise hope of fundamental change in cancer treatment. → Read More
Who killed the COVID vaccine waiver?
The inside story of how lobbying, threats and the desire to protect industry gutted a proposal that was meant to make vaccines widely available in poorer countries. → Read More
Anger and anxiety stalk EU’s monkeypox vaccine lottery
Vaccine tourism is back as people seek to protect themselves against illness and stigma. → Read More
Monkeypox outbreak: What we know so far
Cases of monkeypox are being investigated in several countries in Europe and North America. → Read More
Novavax asks EU to approve coronavirus vaccine for adolescents
Request includes data from an ongoing trial of the jab in teenagers in the US. → Read More
Protesters take to the streets across Europe to oppose invasion of Ukraine
Tens of thousands gathered in cities including Brussels, London, Paris, Munich, Dublin and Geneva. → Read More
Missed handshake at Africa summit has awkward Sofagate echo
Incident after EU-Africa summit had uncomfortable parallels with a diplomatic protocol breach in Turkey last year. → Read More
England’s health service staff to get 3 percent pay rise
England’s National Health Service staff will receive a 3 percent pay rise backdated to April, the U.K. government announced today. The increase comes after an initial offer of 1 percent that … → Read More
Coronavirus vaccine booster trial begins in UK
Study comes as governments debate how to reopen amid concern about the spread of new variants of concern. → Read More
Kurz: Austria concludes Sputnik V negotiations
The European Medicines Agency is still carrying out a rolling review of the Russian jab. → Read More
EU OKs new manufacturing sites for coronavirus vaccines
The regulatory approval means that the EU now has four sites producing the active substance for the Oxford/AstraZeneca jab. → Read More
WHO gives green light to J&J vaccine
This is the third vaccine to receive emergency use listing from the WHO, following Oxford/AstraZeneca and Pfizer/BioNTech. → Read More
WHO coronavirus origins probe in China fails to reveal major new findings
Scientists have yet to identify how the virus began to jump to humans or where this spread began. → Read More
UK approves third coronavirus vaccine, giving OK to Moderna
Britain moves ahead of EU in number of vaccines approved for use. → Read More
BioNTech/Pfizer coronavirus vaccine on course for approval next week
The EU could approve the BioNTech/Pfizer vaccine next week, with a meeting of the committee that recommends a conditional marketing authorization set for December 21. That is eight days soone… → Read More
UK’s speedy coronavirus vaccine approval sparks hope (and questions)
Moving at breakneck speed, the UK is setting its sights on on mass immunization. → Read More
Success in third coronavirus vaccine trial boosts hope COVID-19 can be contained
World Health Organization chief Tedros Adhanom Ghebreyesus said the trial results offered ‘real hope.’ → Read More
AstraZeneca, Oxford: Coronavirus vaccine is 70 percent effective
The announcement comes after news from Moderna and the Pfizer/BioNTech vaccine trials, which both showed efficacy of over 90 percent. → Read More